This Article Free upon publication Full Text Full Text (PDF) Correction (v113,pe682) All Versions of this Article: 112/12/1825    most recent CIRCULATIONAHA.105.167587v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hunt, S. A. Articles by Riegel, B. Search for Related Content PubMed Articles by Hunt, S. A. Articles by Riegel, B. Related Collections AHA Statements and Guidelines

(Circulation. 2005;112:1825-1852.)
© 2005 American Heart Association, Inc.

ACC/AHA Practice Guidelines

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society

WRITING COMMITTEE: Sharon Ann Hunt, MD, FACC, FAHA, Chair; William T. Abraham, MD, FACC, FAHA; Marshall H. Chin, MD, MPH, FACP; Arthur M. Feldman, MD, PhD, FACC, FAHA; Gary S. Francis, MD, FACC, FAHA; Theodore G. Ganiats, MD; Mariell Jessup, MD, FACC, FAHA; Marvin A. Konstam, MD, FACC; Donna M. Mancini, MD; Keith Michl, MD, FACP; John A. Oates, MD, FAHA; Peter S. Rahko, MD, FACC, FAHA; Marc A. Silver, MD, FACC, FAHA; Lynne Warner Stevenson, MD, FACC, FAHA; Clyde W. Yancy, MD, FACC, FAHA

TASK FORCE MEMBERS: Elliott M. Antman, MD, FACC, FAHA, Chair; Sidney C. Smith, Jr, MD, FACC, FAHA, Vice-Chair; Cynthia D. Adams, MSN, APRN-BC, FAHA; Jeffrey L. Anderson, MD, FACC, FAHA; David P. Faxon, MD, FACC, FAHA^*; Valentin Fuster, MD, PhD, FACC, FAHA, FESC^*; Jonathan L. Halperin, MD, FACC, FAHA; Loren F. Hiratzka, MD, FACC, FAHA; Sharon Ann Hunt, MD, FACC, FAHA; Alice K. Jacobs, MD, FACC, FAHA; Rick Nishimura, MD, FACC, FAHA; Joseph P. Ornato, MD, FACC, FAHA; Richard L. Page, MD, FACC, FAHA; Barbara Riegel, DNSc, RN, FAHA

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Table of Contents

 

I. Introduction 1826

II. Characterization of HF as a Clinical Syndrome 1828

A. Definition of HF 1828

B. HF as a Symptomatic Disorder 1828

C. HF as a Progressive Disorder 1829

III. Initial and Serial Clinical Assessment of Patients Presenting With HF 1829

A. Initial Evaluation of Patients 1831

1. Identification of a Structural and Functional Abnormality 1831

2. Evaluation of the Cause of HF 1831

a. History and Physical Examination 1831

b. Laboratory Testing 1831

B. Ongoing Evaluation of Patients 1832

1. Assessment of Volume Status 1832

2. Laboratory Assessment 1832

3. Assessment of Prognosis 1832

IV. Therapy 1832

A. Patients at High Risk for Developing HF (Stage A) 1832

1. Control of Risk 1833

a. Treatment of Hypertension 1833

b. Treatment of Diabetes 1834

c. Management of the Metabolic Syndrome 1834

d. Management of Atherosclerotic Disease 1834

e. Control of Conditions That May Cause Cardiac Injury 1834

f. Other Measures 1834

2. Early Detection of Structural Abnormalities 1834

B. Patients With Cardiac Structural Abnormalities or Remodeling Who Have Not Developed HF Symptoms (Stage B) 1835

1. Prevention of Cardiovascular Events 1835

a. Patients With an Acute MI 1835

b. Patients With Chronic Reduction of LVEF but No Symptoms 1835

C. Patients With Current or Prior Symptoms of HF (Stage C) 1836

1. Patients With Reduced LVEF 1836

a. General Measures 1837

b. Drugs Recommended for Routine Use 1837

c. Interventions to be Considered for Use in Selected Patients 1842

d. Drugs and Interventions Under Active Investigation 1842

e. . . . [Full Text of this Article]

This article has been cited by other articles:

				B. Sassone, L. Gabrieli, S. Sacca, G. Boggian, A. Fusco, C. Pratola, M. L. Bacchi-Reggiani, L. Padeletti, and S. S. Barold Value of right ventricular-left ventricular interlead electrical delay to predict reverse remodelling in cardiac resynchronization therapy: the INTER-V pilot study Europace, November 6, 2009; (2009) eup347v1. [Abstract] [Full Text] [PDF]

				A. Cohen-Solal, D. Kotecha, D. J van Veldhuisen, D. Babalis, M. Bohm, A. J. Coats, M. Roughton, P. Poole-Wilson, L. Tavazzi, M. Flather, et al. Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial Eur J Heart Fail, September 1, 2009; 11(9): 872 - 880. [Abstract] [Full Text] [PDF]

				H. Burri, B. Gerritse, L. Davenport, M. Demas, C. Sticherling, and on behalf of the Concerto AT Clinical Study Invest Fluctuation of left ventricular thresholds and required safety margin for left ventricular pacing with cardiac resynchronization therapy Europace, July 1, 2009; 11(7): 931 - 936. [Abstract] [Full Text] [PDF]

				E. B. Levitan, A. Wolk, and M. A. Mittleman Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men Eur. Heart J., June 2, 2009; 30(12): 1495 - 1500. [Abstract] [Full Text] [PDF]

				E. B. Levitan, A. Wolk, and M. A. Mittleman Consistency With the DASH Diet and Incidence of Heart Failure Arch Intern Med, May 11, 2009; 169(9): 851 - 857. [Abstract] [Full Text] [PDF]

				J. L. Amato Jr., J. L. Amato Sr., J. K. Ghali, H. Tomoda, G. Schillaci, G. Pucci, M. Pirro, B. M. Massie, P. E. Carson, and the I-PRESERVE Investigators Irbesartan for Heart Failure with Preserved Ejection Fraction N. Engl. J. Med., March 19, 2009; 360(12): 1256 - 1259. [Full Text] [PDF]

				G. Mancia Prevention of risk factors: beta-blockade and hypertension Eur. Heart J. Suppl., March 1, 2009; 11(suppl_A): A3 - A8. [Abstract] [Full Text] [PDF]

				G. M. Felker, C. M. O'Connor, E. Braunwald, and for the Heart Failure Clinical Research Network In Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil? Circ Heart Fail, January 1, 2009; 2(1): 56 - 62. [Full Text] [PDF]

				A. H.B. Wu Novel Biomarkers of Cardiovascular Disease: Myeloperoxidase for Acute and/or Chronic Heart Failure? Clin. Chem., January 1, 2009; 55(1): 12 - 14. [Full Text] [PDF]

				K. R. Beich and C. Yancy The Heart Failure and Sodium Restriction Controversy: Challenging Conventional Practice Nutr Clin Pract, October 1, 2008; 23(5): 477 - 486. [Abstract] [Full Text] [PDF]

				D. Lombardo, T. V Bridgeman, N. De Michelis, and M. Nunez An academic medical centre's programme to develop clinical pathways to manage health care: focus on acute decompensated heart failure Intl J Care Pathw, September 1, 2008; 12(2): 45 - 55. [Abstract] [Full Text] [PDF]

				J. W H Fung, G. W K Yip, and C.-M. Yu Does atrial fibrillation preclude biventricular pacing? Heart, July 1, 2008; 94(7): 826 - 827. [Full Text] [PDF]

				V. J Colucci and B. D Berry Heart Failure Worsening and Exacerbation After Venlafaxine and Duloxetine Therapy Ann. Pharmacother., June 1, 2008; 42(6): 882 - 887. [Abstract] [Full Text] [PDF]

				M Imazio, E Cecchi, B Demichelis, A Chinaglia, S Ierna, D Demarie, A Ghisio, F Pomari, R Belli, and R Trinchero Myopericarditis versus viral or idiopathic acute pericarditis Heart, April 1, 2008; 94(4): 498 - 501. [Abstract] [Full Text] [PDF]

				S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628. [Full Text]

				American Diabetes Association Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association Diabetes Care, January 1, 2008; 31(Supplement_1): S61 - S78. [Full Text] [PDF]

				J. Ritzema, I. C. Melton, A. M. Richards, I. G. Crozier, C. Frampton, R. N. Doughty, J. Whiting, S. Kar, N. Eigler, H. Krum, et al. Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device Circulation, December 18, 2007; 116(25): 2952 - 2959. [Abstract] [Full Text] [PDF]

				F. Cabrera-Bueno, J. M. Garcia-Pinilla, J. Pena-Hernandez, M. Jimenez-Navarro, J. J. Gomez-Doblas, A. Barrera-Cordero, J. Alzueta-Rodriguez, and E. de Teresa-Galvan Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy Europace, September 1, 2007; 9(9): 757 - 761. [Abstract] [Full Text] [PDF]

				C. B. Bucca, L. Brussino, A. Battisti, R. Mutani, G. Rolla, L. Mangiardi, and A. Cicolin Diuretics in Obstructive Sleep Apnea With Diastolic Heart Failure Chest, August 1, 2007; 132(2): 440 - 446. [Abstract] [Full Text] [PDF]

				G. Piccirillo, D. Magri, S. Matera, M. Magnanti, A. Torrini, E. Pasquazzi, E. Schifano, S. Velitti, V. Marigliano, R. Quaglione, et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study Eur. Heart J., June 1, 2007; 28(11): 1344 - 1350. [Abstract] [Full Text] [PDF]

				G. J. Balady, M. A. Williams, P. A. Ades, V. Bittner, P. Comoss, J. M. Foody, B. Franklin, B. Sanderson, and D. Southard Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update: A Scientific Statement From the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation Circulation, May 22, 2007; 115(20): 2675 - 2682. [Abstract] [Full Text] [PDF]

				G. C. Fonarow, W. F. Peacock, C. O. Phillips, M. M. Givertz, M. Lopatin, and for the ADHERE Scientific Advisory Committee and I Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1943 - 1950. [Abstract] [Full Text] [PDF]

				K. A. Ammar, S. J. Jacobsen, D. W. Mahoney, J. A. Kors, M. M. Redfield, J. C. Burnett Jr, and R. J. Rodeheffer Prevalence and Prognostic Significance of Heart Failure Stages: Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in the Community Circulation, March 27, 2007; 115(12): 1563 - 1570. [Abstract] [Full Text] [PDF]

				M. R. Costanzo, M. E. Guglin, M. T. Saltzberg, M. L. Jessup, B. A. Bart, J. R. Teerlink, B. E. Jaski, J. C. Fang, E. D. Feller, G. J. Haas, et al. Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure J. Am. Coll. Cardiol., February 13, 2007; 49(6): 675 - 683. [Abstract] [Full Text] [PDF]

				S. C. Inglis, S. Pearson, S. Treen, T. Gallasch, J. D. Horowitz, and S. Stewart Extending the Horizon in Chronic Heart Failure: Effects of Multidisciplinary, Home-Based Intervention Relative to Usual Care Circulation, December 5, 2006; 114(23): 2466 - 2473. [Abstract] [Full Text] [PDF]

				K. Zerumsky and B. F. McBride Ranolazine in the management of chronic stable angina Am. J. Health Syst. Pharm., December 1, 2006; 63(23): 2331 - 2338. [Abstract] [Full Text] [PDF]

				H. Skali, M. A. Pfeffer, J. Lubsen, and S. D. Solomon Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials Circulation, November 21, 2006; 114(21): 2298 - 2303. [Abstract] [Full Text] [PDF]

				D. G. Renlund and A. G. Kfoury When the Failing, End-Stage Heart Is Not End-Stage N. Engl. J. Med., November 2, 2006; 355(18): 1922 - 1925. [Full Text] [PDF]

				C. A. Fiack, H. W. Farber, M. A. Arias, A. Alonso-Fernandez, F. Garcia-Rio, K. M. Kessler, A. Ahmed, J. L. Fleg, M. Gheorghiade, T. E. Owan, et al. Heart failure with preserved ejection fraction. N. Engl. J. Med., October 26, 2006; 355(17): 1828 - 1828. [Full Text] [PDF]

				M. P. Donahue, D. A. Marchuk, and H. A. Rockman Redefining Heart Failure: The Utility of Genomics J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1289 - 1298. [Abstract] [Full Text] [PDF]

				A. Curcio, T. Noma, S. V. Naga Prasad, M. J. Wolf, A. Lemaire, C. Perrino, L. Mao, and H. A. Rockman Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1754 - H1760. [Abstract] [Full Text] [PDF]

				American Diabetes Association Nutrition Recommendations and Interventions for Diabetes-2006: A position statement of the American Diabetes Association. Diabetes Care, September 1, 2006; 29(9): 2140 - 2157. [Full Text] [PDF]

				P. A Howard, J. W. Cheng, M. A Crouch, V. J Colucci, J. S Kalus, S. A Spinler, and M. Munger Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure Ann. Pharmacother., September 1, 2006; 40(9): 1607 - 1616. [Abstract] [Full Text] [PDF]

				J. G.F. Cleland, J.-C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, L. Tavazzi, and on behalf of The CARE-HF Study Investigators Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur. Heart J., August 2, 2006; 27(16): 1928 - 1932. [Abstract] [Full Text] [PDF]

				P. Lechat The evolution of heart failure management over recent decades: from CONSENSUS to CIBIS Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C5 - C12. [Abstract] [Full Text] [PDF]

				P. Ponikowski Rationale and design of CIBIS III Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C35 - C42. [Abstract] [Full Text] [PDF]

				R. Willenheimer How to begin treatment in chronic heart failure? Results of CIBIS III Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C43 - C50. [Abstract] [Full Text] [PDF]

				Y.-D. Tang and S. D. Katz Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options Circulation, May 23, 2006; 113(20): 2454 - 2461. [Full Text] [PDF]

				B. J. Maron, J. A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A. J. Moss, C. E. Seidman, and J. B. Young Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation, April 11, 2006; 113(14): 1807 - 1816. [Abstract] [Full Text] [PDF]

				O.-A. Breithardt and G. Breithardt Quest for the Best Candidate: How Much Imaging Do We Need Before Prescribing Cardiac Resynchronization Therapy? Circulation, February 21, 2006; 113(7): 926 - 928. [Full Text] [PDF]

				J. W. Magnani and G. W. Dec Myocarditis: Current Trends in Diagnosis and Treatment Circulation, February 14, 2006; 113(6): 876 - 890. [Full Text] [PDF]

				M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. L. Pina, M. A. Konstam, B. M. Massie, E. Roland, S. Targum, S. P. Collins, et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research Circulation, December 20, 2005; 112(25): 3958 - 3968. [Full Text] [PDF]

				M. L. King, M. A. Williams, G. F. Fletcher, N. F. Gordon, M. Gulanick, C. N. King, A. S. Leon, B. D. Levine, F. Costa, and N. K. Wenger Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs: A Scientific Statement From the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation Circulation, November 22, 2005; 112(21): 3354 - 3360. [Full Text] [PDF]